The impact of overweight on diverticular disease: a cross-sectional multicentre study

Mari, Amir; Sbeit, Wisam; Haddad, Henry; Abboud, Wisam; Pellicano, Rinaldo; Khoury, Tawfik

doi:10.20452/pamw.16177

Cited by 3 publications

(1 citation statement)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Non-alcoholic fatty liver disease (NAFLD) is a common liver disease present in a large percent of people with obesity [6][7][8]. NAFLD is related to various health complications, from simple hepatic steatosis and non-alcoholic steatohepatitis (NASH), cirrhosis, hepatocellular carcinoma and even death [8][9][10][11]. Patients with severe obesity referred for the bariatric surgery belong to a high risk group for NAFLD [12].…”

Section: Introductionmentioning

confidence: 99%

Ultrasound and biomarker based assessment of hepatic steatosis in patients with severe obesity

Byra¹,

Szmigielski²,

Kalinowski³

et al. 2022

Polish Archives of Internal Medicine

View full text Add to dashboard Cite

Non-alcoholic fatty liver disease (NAFLD) is among the most common liver abnormalities. Various methods based on ultrasound imaging and clinical biomarkers have been proposedfor the non-invasive diagnosis of the fatty liver disease in the general population. However, the usefulness of these methods for the patients with severe obesity has not been adequately investigated yet. In this work, we compare the fatty liver disease classification performance of the ultrasound hepatorenal index technique, the hepatic steatosis index and the NAFLD logit score technique in patients with severe obesity. Results demonstrate that the investigated methods require adjustments in order to work well in patients with severe obesity. Our study also indicates that the ultrasound hepatorenal index method outperforms biomarker-based techniques.

show abstract